Please use this identifier to cite or link to this item:
|Title:||Liposomal-benzocaine gel formulation: correlation between in vitro assays and in vivo topical anesthesia in volunteers|
Cereda, C. M. S.
da Silva, C. M. G.
de Araujo, D. R.
Novaes, P. D.
Groppo, F. C.
de Paula, E.
|Abstract:||The aim of the present study was to characterize a liposome-based benzocaine (BZC) formulation designed for topical use on the oral mucosa and to evaluate its in vitro retention and permeation using the Franz-type diffusion cells through pig esophagus mucosa. To predict the effectiveness of new designed formulations during preclinical studies, a correlation between in vitro assays and in vivo efficacy was performed. Liposomal BZC was characterized in terms of membrane/water partition coefficient, encapsulation efficiency, size, polydispersity, zeta potential, and morphology. Liposomal BZC (BL10) was incorporated into gel formulation and its performances were compared to plain BZC gel (B10) and the commercially available BZC gel (B20). BL10 and B10 presented higher flux and retention on pig esophagus mucosa with a shorter lag time, when compared to B20. BZC flux was strongly correlated with in vivo anesthetic efficacy, but not with topical anesthesia duration. The retention studies did not correlate with any of the in vivo efficacy parameters. Thus, in vitro permeation study can be useful to predict anesthetic efficacy during preclinical tests, because a correlation between flux and anesthetic efficacy was observed. Therefore, in vitro assays, followed by in vivo efficacy, are necessary to confirm anesthetic performance|
|Editor:||Taylor & Francis|
|Citation:||Journal Of Liposome Research. Informa Healthcare, v. 23, n. 1, n. 54, n. 60, 2013.|
|Appears in Collections:||IB - Artigos e Outros Documentos|
FOP - Artigos e Outros Documentos
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.